©The Author(s) 2015.
World J Hepatol. Mar 27, 2015; 7(3): 507-520
Published online Mar 27, 2015. doi: 10.4254/wjh.v7.i3.507
Published online Mar 27, 2015. doi: 10.4254/wjh.v7.i3.507
Table 2 2005 World Congress of Gastroenterology diagnostic and supportive criteria for cirrhotic cardiomyopathy[1]
| A working definition of cirrhotic cardiomyopathy |
| A cardiac dysfunction in patients with cirrhosis characterised byimpaired contractile responsiveness to stress and/or altered diastolicrelaxation with electrophysiological abnormalities in the absence ofother known cardiac disease |
| Diagnostic criteria |
| Systolic dysfunction |
| Blunted increase in cardiac output on exercise, volume challenge orpharmacological stimuli |
| Resting LVEF < 55% |
| Diastolic dysfunction |
| E/A ratio < 1 (age-corrected) |
| Prolonged deceleration time (> 200 ms) |
| Prolonged isovolumetric relaxation time (> 80 ms) |
| Supportive criteria |
| Electrophysiological abnormalities |
| Abnormal chronotropic response |
| Electromechanical uncoupling |
| Prolonged QTc interval |
| Enlarged left atrium |
| Increased myocardial mass |
| Increased BNP (brain natriuretic peptide) and pro-BNP |
| Increased troponinI |
- Citation: Rahman S, Mallett SV. Cirrhotic cardiomyopathy: Implications for the perioperative management of liver transplant patients. World J Hepatol 2015; 7(3): 507-520
- URL: https://www.wjgnet.com/1948-5182/full/v7/i3/507.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i3.507